Literature DB >> 12047266

Review article: gastric cancer and Helicobacter pylori.

A Axon1.   

Abstract

Gastric cancer is the second commonest cause of death from malignancy in the world. Its pathogenesis is comparatively well understood and its aetiology multifactorial. Non-cardia gastric cancer usually arises in a stomach that has been inflamed over a long period and where atrophy and intestinal metaplasia have supervened. The commonest cause of gastric inflammation is infection with Helicobacter pylori. Colonization with this organism increases the relative risk of developing this cancer by about six [Helicobacter and Cancer Collaborative Group. Gut 2001; 49: 347-53]. Its likelihood increases with the severity and extent of the gastritis. Severity is influenced by the virulence of the infecting organism, the genetics of the host, bile reflux, dietary factors and the presence of hypochlorhydria which influences the extent, as well as the severity, of the inflammation. The only predisposing factor which can easily be manipulated is H. pylori infection, which can be successfully treated in 80-90% of cases using a 1-week therapeutic regimen.

Entities:  

Mesh:

Year:  2002        PMID: 12047266     DOI: 10.1046/j.1365-2036.16.s4.14.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  10 in total

1.  Prevalence of Helicobacter pylori infection and intestinal metaplasia in subjects who had undergone surgery for gastric adenocarcinoma in Northwest Italy.

Authors:  Giorgio Palestro; Rinaldo Pellicano; Gian Ruggero Fronda; Guido Valente; Marco De Giuli; Tito Soldati; Agostino Pugliese; Stefano Taraglio; Mauro Garino; Donata Campra; Miguel Angel Cutufia; Elena Margaria; Giancarlo Spinzi; Aldo Ferrara; Giorgio Marenco; Mario Rizzetto; Antonio Ponzetto
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

2.  In Situ Detection of Bacteria within Paraffin-embedded Tissues Using a Digoxin-labeled DNA Probe Targeting 16S rRNA.

Authors:  Yun Sik Choi; Yong Cheol Kim; Keum Jin Baek; Youngnim Choi
Journal:  J Vis Exp       Date:  2015-05-21       Impact factor: 1.355

Review 3.  Helicobacter pylori infection causes gastric cancer? A review of the epidemiological, meta-analytic, and experimental evidence.

Authors:  Guy-D Eslick
Journal:  World J Gastroenterol       Date:  2006-05-21       Impact factor: 5.742

4.  H. pylori infection is a key risk factor for proximal gastric cancer.

Authors:  Jan Bornschein; Michael Selgrad; Maren Warnecke; Doerthe Kuester; Thomas Wex; Peter Malfertheiner
Journal:  Dig Dis Sci       Date:  2010-07-29       Impact factor: 3.199

5.  The association of drinking water quality and sewage disposal with Helicobacter pylori incidence in infants: the potential role of water-borne transmission.

Authors:  Penny B Travis; Karen J Goodman; Kathleen M O'Rourke; Frank D Groves; Debajyoti Sinha; Joyce S Nicholas; Jim VanDerslice; Daniel Lackland; Kristina D Mena
Journal:  J Water Health       Date:  2010-03       Impact factor: 1.744

6.  Activation of abl family kinases in solid tumors.

Authors:  Sourik S Ganguly; Rina Plattner
Journal:  Genes Cancer       Date:  2012-05

7.  Activated Akt as an indicator of prognosis in gastric cancer.

Authors:  Caterina Cinti; Carla Vindigni; Alessandra Zamparelli; Dario La Sala; Maria Carmela Epistolato; Daniele Marrelli; Gabriele Cevenini; Piero Tosi
Journal:  Virchows Arch       Date:  2008-10-08       Impact factor: 4.064

Review 8.  Gastric cancer-molecular and clinical dimensions.

Authors:  Roopma Wadhwa; Shumei Song; Ju-Seog Lee; Yixin Yao; Qingyi Wei; Jaffer A Ajani
Journal:  Nat Rev Clin Oncol       Date:  2013-09-24       Impact factor: 66.675

Review 9.  Follow the Metaplasia: Characteristics and Oncogenic Implications of Metaplasia's Pattern of Spread Throughout the Stomach.

Authors:  José B Sáenz
Journal:  Front Cell Dev Biol       Date:  2021-11-12

10.  Marital status and survival in patients with gastric cancer.

Authors:  Jie-Jie Jin; Wei Wang; Fa-Xiang Dai; Zi-Wen Long; Hong Cai; Xiao-Wen Liu; Ye Zhou; Hua Huang; Ya-Nong Wang
Journal:  Cancer Med       Date:  2016-06-05       Impact factor: 4.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.